Internal Medicine · Torrance, CA
NPI
1407053416
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 W Carson St
Torrance, CA, 90502
Phone (310) 222-2401
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
2,222 services
Medicare patients, 2024
15
Average age 65
Drug cost, 2024
$4.6M
1,314 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rashmi K Menon prescribed most often to Medicare patients was Letrozole, with 146 prescriptions and refills. In total Rashmi K Menon wrote 1,314 Medicare prescriptions that cost $4.6M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Letrozole Generic | 146 | 413 | 39 | $2,842 |
| Anastrozole Generic | 145 | 379 | 42 | $3,630 |
| Ibrance Palbociclib | 90 | 90 | Under 11 | $1.4M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 51 | 51 | Under 11 | $1,090 |
| Dexamethasone Generic | 43 | 52 | 16 | $554 |
| Lenalidomide Generic | 41 | 41 | Under 11 | $453K |
| Tamoxifen Citrate Generic | 33 | 107 | 11 | $856 |
| Omeprazole Generic | 32 | 83 | 11 | $286 |
| Gabapentin Generic | 29 | 69 | Under 11 | $723 |
| Xarelto Rivaroxaban | 28 | 37 | Under 11 | $17K |
| Trazodone Hcl Generic | 28 | 33 | Under 11 | $211 |
| Hydroxyurea Generic | 28 | 90 | Under 11 | $1,388 |
| Prednisone Generic | 27 | 61 | 13 | $276 |
| Venclexta Venetoclax | 23 | 23 | Under 11 | $284K |
| Abiraterone Acetate Generic | 23 | 27 | Under 11 | $4,079 |
Brand drugs: 335 claims; generic drugs: 979 claims; opioid claims: 120.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rashmi K Menon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.